Evidence map›Paper›PMID 37101022›Full record

ArticleWiener klinische Wochenschrift2023

[Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)].

Susanne Kaser, Sabine E Hofer, Lili Kazemi-Shirazi, Andreas Festa, Yvonne Winhofer, Harald Sourij, Helmut Brath, Michaela Riedl, Michael Resl, Martin Clodi and 3 more

Open access · hybridAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Susanne KaserUniversitätsklinik für Innere Medizin 1, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich. susanne.kaser@i-med.ac.at.
Sabine E HoferUniversitätsklinik für Pädiatrie 1, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Lili Kazemi-ShiraziKlinische Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Andreas FestaAbteilung für Innere Medizin I, LK Stockerau, Stockerau, Österreich.
Yvonne WinhoferKlinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Harald SourijKlinische Abteilung für Endokrinologie und Diabetologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Österreich.
Helmut BrathMein Gesundheitszentrum Favoriten, Österreichische Gesundheitskasse, Wien, Österreich.
Michaela RiedlKlinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Michael ReslAbteilung für Innere Medizin, Konventhospital der Barmherzigen Brüder Linz, Linz, Österreich.
Martin ClodiAbteilung für Innere Medizin, Konventhospital der Barmherzigen Brüder Linz, Linz, Österreich.
Thomas Stulnig3. Medizinische Abteilung und Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Klinik Hietzing, Wien, Österreich.
Claudia RessUniversitätsklinik für Innere Medizin 1, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich.
Anton LugerKlinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Medical University of Vienna · ATInnsbruck Medical University · ATConvent Hospital of the Brothers of Saint John of God · ATGesundheit Österreich · ATKlinik Hietzing · ATLink Institut (Switzerland) · CHMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The heterogenous category "specific types of diabetes due to other causes" encompasses disturbances in glucose metabolism due to other endocrine disorders such as acromegaly or hypercortisolism, drug-induced diabetes (e.g. antipsychotic medications, glucocorticoids, immunosuppressive agents, highly active antiretroviral therapy (HAART), checkpoint inhibitors), genetic forms of diabetes (e.g. Maturity Onset Diabetes of the Young (MODY), neonatal diabetes, Down‑, Klinefelter- and Turner Syndrome), pancreatogenic diabetes (e.g. postoperatively, pancreatitis, pancreatic cancer, haemochromatosis, cystic fibrosis), and some rare autoimmune or infectious forms of diabetes. Diagnosis of specific diabetes types might influence therapeutic considerations. Exocrine pancreatic insufficiency is not only found in patients with pancreatogenic diabetes but is also frequently seen in type 1 and long-standing type 2 diabetes.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesExocrine Pancreatic InsufficiencyPancreatic NeoplasmsHumansInfant, NewbornDiabetes due to other endocrine disordersDrug induced diabetesExocrine pancreatic insufficiencyGenetic diabetes formsOther specific diabetes types

Identifiers

PMID37101022
PMCPMC10133035
OpenAlexW4367162888

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.